Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Payables (2020 - 2026)

Treace Medical Concepts filings provide 6 years of Payables readings, the most recent being $8.5 million for Q4 2025.

  • On a quarterly basis, Payables fell 19.49% to $8.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $8.5 million, a 19.49% decrease, with the full-year FY2025 number at $8.5 million, down 19.49% from a year prior.
  • Payables hit $8.5 million in Q4 2025 for Treace Medical Concepts, down from $17.9 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $21.1 million in Q1 2024 to a low of $1.3 million in Q1 2021.
  • Median Payables over the past 5 years was $8.6 million (2022), compared with a mean of $9.8 million.
  • Biggest five-year swings in Payables: soared 316.65% in 2024 and later tumbled 37.26% in 2025.
  • Treace Medical Concepts' Payables stood at $4.1 million in 2021, then surged by 113.71% to $8.7 million in 2022, then surged by 36.54% to $11.8 million in 2023, then decreased by 11.09% to $10.5 million in 2024, then decreased by 19.49% to $8.5 million in 2025.
  • The last three reported values for Payables were $8.5 million (Q4 2025), $17.9 million (Q3 2025), and $21.1 million (Q2 2025) per Business Quant data.